You have 1 action to finish to complete your account. Craft your experience by picking your interest on the Personalisation Page
Dermatology

Urticaria Centers of Reference and Excellence (UCARE) 2023 | São Paulo

Exploring the role of type 2 inflammation and the neuroimmune axis in CSU, and how emerging therapeutics are targeting key molecules in these pathways.

Marcus Maurer
Brian Kim
Luis Felipe Ensina
MD
Marcus Maurer +3 more
Past event
8December2023
Location
Rebouças Convention Center, Grande Auditório
São Paulo Brazil

Learning objectives

  • Enhance awareness of emerging clinical trial data in CSU
  • Learn about the role of type 2 inflammation in the pathogenesis of CSU
  • Explore the role of the neuroimmune axis in CSU

Description

Targeting Type 2 Inflammation in CSU – Clinical and Mechanistic Implications

Symposium focusing on the key roles of type 2 inflammation and the neuroimmune axis in CSU pathophysiology. Current understanding of these pathways has guided development of emerging therapeutics that target molecular drivers within type 2 inflammation, from which Phase 3 efficacy and safety data are presented and explored. Dr. Ensina guides discussions on the perspective of CSU management in Brazil. Dr. Maurer explores current clinical data from leading emerging therapies in CSU. Drs. Saini and Kim provide a deep dive into the pathophysiology of type 2 inflammation and the neuroimmune axis in CSU.

Agenda:

  1. Welcome & IntroductionMarcus Maurer (Chair)

  2. CSU – The Brazil PerspectiveLuis Felipe Ensina

  3. Emerging Clinical Trial Data in CSUMarcus Maurer

  4. Role of Type 2 Inflammation in CSU PathogenesisSarbjit Saini

  5. Neuronal Involvement in CSUBrian Kim

  6. Panel Discussion/Q&A, All faculty

 

MAT-GLB-2303901 V1 12/2023

Location
Rebouças Convention Center, Grande Auditório
São Paulo Brazil

Speakers